BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

604 related articles for article (PubMed ID: 24677054)

  • 21. (-)-Epicatechin 3-O-β-D-allopyranoside prevent ovariectomy-induced bone loss in mice by suppressing RANKL-induced NF-κB and NFATc-1 signaling pathways.
    Hsiao HB; Wu JB; Lin WC
    BMC Complement Altern Med; 2017 May; 17(1):245. PubMed ID: 28468652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Supportive Role of Probiotic Strains in Protecting Rats from Ovariectomy-Induced Cortical Bone Loss.
    Montazeri-Najafabady N; Ghasemi Y; Dabbaghmanesh MH; Talezadeh P; Koohpeyma F; Gholami A
    Probiotics Antimicrob Proteins; 2019 Dec; 11(4):1145-1154. PubMed ID: 30014348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kinsenoside prevents ovariectomy-induced bone loss and suppresses osteoclastogenesis by regulating classical NF-κB pathways.
    Hsiao HB; Lin H; Wu JB; Lin WC
    Osteoporos Int; 2013 May; 24(5):1663-76. PubMed ID: 23143538
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cajaninstilbene acid inhibits osteoporosis through suppressing osteoclast formation and RANKL-induced signaling pathways.
    Sun Y; Liu Y; He W; Wang C; Tickner J; Kuek V; Zhou C; Wang H; Zou X; Hong Z; Yang F; Shao M; Chen L; Xu J
    J Cell Physiol; 2019 Jul; 234(7):11792-11804. PubMed ID: 30515822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-osteoporotic activity of harpagide by regulation of bone formation in osteoblast cell culture and ovariectomy-induced bone loss mouse models.
    Chung HJ; Kyung Kim W; Joo Park H; Cho L; Kim MR; Kim MJ; Shin JS; Ho Lee J; Ha IH; Kook Lee S
    J Ethnopharmacol; 2016 Feb; 179():66-75. PubMed ID: 26712566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Turbo methanol extract inhibits bone resorption through regulation of T cell function.
    Balakrishnan B; Indap MM; Singh SP; Krishna CM; Chiplunkar SV
    Bone; 2014 Jan; 58():114-25. PubMed ID: 24140785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of anti-IL-23 monotherapy versus combination therapy with anti-IL-17 in estrogen deficiency induced bone loss conditions.
    Shukla P; Mansoori MN; Singh D
    Bone; 2018 May; 110():84-95. PubMed ID: 29414600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Strain-dependent variations in the response of cancellous bone to ovariectomy in mice.
    Iwaniec UT; Yuan D; Power RA; Wronski TJ
    J Bone Miner Res; 2006 Jul; 21(7):1068-74. PubMed ID: 16813527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estrogen Deficiency-Mediated M2 Macrophage Osteoclastogenesis Contributes to M1/M2 Ratio Alteration in Ovariectomized Osteoporotic Mice.
    Dou C; Ding N; Zhao C; Hou T; Kang F; Cao Z; Liu C; Bai Y; Dai Q; Ma Q; Luo F; Xu J; Dong S
    J Bone Miner Res; 2018 May; 33(5):899-908. PubMed ID: 29281118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Triptolide prevents bone loss via suppressing osteoclastogenesis through inhibiting PI3K-AKT-NFATc1 pathway.
    Cui J; Li X; Wang S; Su Y; Chen X; Cao L; Zhi X; Qiu Z; Wang Y; Jiang H; Huang B; Ji F; Su J
    J Cell Mol Med; 2020 Jun; 24(11):6149-6161. PubMed ID: 32347017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ovariectomy increases RANKL protein expression in bone marrow adipocytes of C3H/HeJ mice.
    Beekman KM; Zwaagstra M; Veldhuis-Vlug AG; van Essen HW; den Heijer M; Maas M; Kerckhofs G; Parac-Vogt TN; Bisschop PH; Bravenboer N
    Am J Physiol Endocrinol Metab; 2019 Dec; 317(6):E1050-E1054. PubMed ID: 31526291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bioactive iron oxide nanoparticles suppress osteoclastogenesis and ovariectomy-induced bone loss through regulating the TRAF6-p62-CYLD signaling complex.
    Liu L; Jin R; Duan J; Yang L; Cai Z; Zhu W; Nie Y; He J; Xia C; Gong Q; Song B; Anderson JM; Ai H
    Acta Biomater; 2020 Feb; 103():281-292. PubMed ID: 31866569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The naturally derived small compound Osthole inhibits osteoclastogenesis to prevent ovariectomy-induced bone loss in mice.
    Zhao D; Wang Q; Zhao Y; Zhang H; Sha N; Tang D; Liu S; Lu S; Shi Q; Zhang Y; Dong Y; Wang Y; Shu B
    Menopause; 2018 Dec; 25(12):1459-1469. PubMed ID: 29944638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Short-Term Hypoxia Accelerates Bone Loss in Ovariectomized Rats by Suppressing Osteoblastogenesis but Enhancing Osteoclastogenesis.
    Wang G; Wang J; Sun D; Xin J; Wang L; Huang D; Wu W; Xian CJ
    Med Sci Monit; 2016 Aug; 22():2962-71. PubMed ID: 27550548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LIGHT/TNFSF14 regulates estrogen deficiency-induced bone loss.
    Brunetti G; Storlino G; Oranger A; Colaianni G; Faienza MF; Ingravallo G; Di Comite M; Reseland JE; Celi M; Tarantino U; Passeri G; Ware CF; Grano M; Colucci S
    J Pathol; 2020 Apr; 250(4):440-451. PubMed ID: 31990039
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pseurotin A Inhibits Osteoclastogenesis and Prevents Ovariectomized-Induced Bone Loss by Suppressing Reactive Oxygen Species.
    Chen K; Qiu P; Yuan Y; Zheng L; He J; Wang C; Guo Q; Kenny J; Liu Q; Zhao J; Chen J; Tickner J; Fan S; Lin X; Xu J
    Theranostics; 2019; 9(6):1634-1650. PubMed ID: 31037128
    [No Abstract]   [Full Text] [Related]  

  • 37. REV-ERB agonism suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss partially via FABP4 upregulation.
    Song C; Tan P; Zhang Z; Wu W; Dong Y; Zhao L; Liu H; Guan H; Li F
    FASEB J; 2018 Jun; 32(6):3215-3228. PubMed ID: 29401617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lactobacillus reuteri 6475 Increases Bone Density in Intact Females Only under an Inflammatory Setting.
    Collins FL; Irwin R; Bierhalter H; Schepper J; Britton RA; Parameswaran N; McCabe LR
    PLoS One; 2016; 11(4):e0153180. PubMed ID: 27058036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostaglandin E2 induces expression of receptor activator of nuclear factor-kappa B ligand/osteoprotegrin ligand on pre-B cells: implications for accelerated osteoclastogenesis in estrogen deficiency.
    Kanematsu M; Sato T; Takai H; Watanabe K; Ikeda K; Yamada Y
    J Bone Miner Res; 2000 Jul; 15(7):1321-9. PubMed ID: 10893680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Siglec-15 is a potential therapeutic target for postmenopausal osteoporosis.
    Kameda Y; Takahata M; Mikuni S; Shimizu T; Hamano H; Angata T; Hatakeyama S; Kinjo M; Iwasaki N
    Bone; 2015 Feb; 71():217-26. PubMed ID: 25460183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.